Epirubicin 100

Epirubicin 100 mg Injection
Epirubicin 100 mg Injection is an anthracycline antineoplastic antibiotic used extensively in combination chemotherapy regimens for the management of various cancers. It acts by inhibiting DNA and RNA synthesis in rapidly dividing cancer cells, resulting in effective tumor control.
Product Details
Generic Name: Epirubicin (as Epirubicin Hydrochloride)
Strength: 100 mg
Dosage Form: Injection (Sterile solution for intravenous use)
Route of Administration: Intravenous (IV)
Therapeutic Class: Anthracycline Anticancer Agent
Indications
Epirubicin 100 mg Injection is indicated for the treatment of:
Breast cancer
Gastric cancer
Ovarian cancer
Lung cancer
Soft tissue sarcomas
Hodgkin’s and Non-Hodgkin’s lymphomas
Mechanism of Action
Epirubicin intercalates into DNA strands and inhibits topoisomerase II, preventing DNA replication and repair. This results in cell cycle arrest and cancer cell death.
Key Benefits
Broad-spectrum antitumor activity
Effective in combination chemotherapy regimens
Dose-related improved cardiac safety profile compared to some other anthracyclines
Widely used in standard oncology treatment protocols
Dosage & Administration
Dosage is individualized based on body surface area (BSA), cancer type, and patient condition. Administration should be performed only under strict medical supervision by qualified healthcare professionals.
Storage Conditions
Store at 2°C to 8°C (Refrigerated)
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Regular monitoring of cardiac function and blood counts is recommended
Use with caution in patients with hepatic impairment